CHina Registry for the chAracteristics and Management strategieS of patiEnts With Pulmonary Hypertension Using Targeted Therapy, CHASE Study - Trial NCT06135909
Access comprehensive clinical trial information for NCT06135909 through Pure Global AI's free database. This phase not specified trial is sponsored by Chinese Pulmonary Vascular Disease Research Group and is currently Not yet recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 5000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Chinese Pulmonary Vascular Disease Research Group
Timeline & Enrollment
N/A
Dec 01, 2023
Dec 31, 2027
Primary Outcome
Incidence of clinical worsening events 1 year after enrollment
Summary
CHina Registry for the chAracteristics and Management strategieS of patiEnts With Pulmonary
 Hypertension Using Targeted Therapy (CHASE Study)
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06135909
Non-Device Trial